Efficacy of the addition of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: a double-blind, randomized, placebo-controlled trial

Efficacy of the addition of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: a double-blind, randomized, placebo-controlled trial
复制标题

添加度洛西汀治疗阿片类药物和加巴喷丁类药物难治的神经性癌症疼痛的疗效:一项双盲、随机、安慰剂对照试验

DOI:
--
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Hiromichi Matsuoka
Hiromichi Matsuoka
中科院分区:
--
文献类型:
--
作者:
Tahata Y;Hiramatsu N;Oze T;Urabe A;Morishita N;Yamada R;Yakushijin T;Hosui A;Oshita M;Kaneko A;Hagiwara H;Mita E;Ito T;Yamada Y;Inada M;Katayama K;Tamura S;Imai Y;Hikita H;Sakamori R;Yoshida Y;Tatsumi T;Hayashi N;Takehara T.;Hiromichi Matsuoka

文献摘要

相似文献